
David Ridley, PhD, is a health economist and Professor of the Practice at Duke University’s Fuqua School of Business, where he has served as Faculty Director of Health Sector Management (HSM) since 2013. HSM students comprise about 20 percent of Duke MBA graduates each year.
David’s research examines biopharmaceutical innovation, regulation, competition, pricing, and access. His work has appeared in Management Science, The Review of Economics and Statistics, Nature Reviews Drug Discovery, and Health Affairs.
David’s research has also shaped federal policy. He was the lead author of the article that proposed the Food and Drug Administration’s priority review voucher program, which Congress enacted in 2007 to encourage development of treatments for neglected diseases. The program created a multibillion-dollar market and helped save lives.
Email: david.ridley@duke.edu
Telephone: +1.919.660.3784
Mail: Duke University, The Fuqua School of Business, 100 Fuqua Drive, Durham, NC 27708-0120